Attorneys say the FDA is unlikely to challenge the court’s decision, though Congress could still look to modernize lab test ...

Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston ...

Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which ...

CFO Joe Wolk, who revealed the figure Tuesday morning on CNBC, told investors the charge was primarily in the healthcare ...

The median deal size for late-stage funding rounds was $105 million, nearly double the $55 million check size across 2024.

CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs.

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

The merger brings together Neurolutions’ brain computer interface technology and Kandu Health’s telehealth services to try to ...

Amid the whirlwind of tariff news, AdvaMed and other healthcare groups have pleaded for the Trump administration to exempt ...

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

CFO Jamie Samath said in January that the stapler clearance would trigger the start of “broad commercial efforts” for the ...

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.